advanced search

Welcome: Guest

log in

Analgesics in Norway

Publication Date June 2009
Publisher Euromonitor
Product Type Report
Pages 38
ISBN Number not applicable
Product Code EUR00666
Buy this product or for assistance call +44 20 7060 7474

Summary

Euromonitor International's Analgesics in Norway report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2003-2008), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2013 illustrate how the market is set to change.

Product coverage:

adult analgesics, child-specific analgesics, systemic analgesics, topical analgesics

Data coverage:

market sizes (historic and forecasts), company shares, brand shares

Why buy this report?

  • Get a detailed picture of the analgesics industry
  • Pinpoint growth sectors and trends and identify factors driving change
  • Understand the competitive environment, the market's major players and leading brands
  • Use five-year forecasts to assess how the market is predicted to develop

Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilniuis, Dubai, Cape Town and Santiago and a network of over 600 analysts worldwide, Euromonitor has a unique capability to develop reliable information resources to help drive informed strategic planning.

Content

  • Analgesics in Norway
  • Euromonitor International
  • June 2009
  • List of Contents and Tables
    • Executive Summary
    • OTC Healthcare Market Characterised by Preventative and Simple Remedies
    • Marketing Plays Critical Role in Selling Products
    • Fragmentation Characterises Competitive Environment
    • Pharmacies Develop Loyal and Satisfied Customer Base
    • Moderate Growth Predicted Over Forecast Period
    • Key Trends and Developments
    • Brand Dynamics Become More Important
    • Pharmacies Have Loyal and Satisfied Customers
    • Debate Continues Regarding Price Sensitivity of OTC Healthcare Products
    • Norwegians More Open To Self-medication
    • Online Shopping on the Horizon
    • Market Indicators
    • Table 1 Consumer Expenditure on Health Goods and Medical Services 2003-2008
    • Table 2 Life Expectancy at Birth 2003-2008
    • Market Data
    • Table 3 Sales of OTC Healthcare by Sector: Value 2003-2008
    • Table 4 Sales of OTC Healthcare by Sector: % Value Growth 2003-2008
    • Table 5 OTC Healthcare Company Shares by Value 2004-2008
    • Table 6 OTC Healthcare Brand Shares by Value 2005-2008
    • Table 7 Sales of OTC Healthcare by Distribution Format: % Analysis 2003-2008
    • Table 8 Sales of OTC Healthcare by Sector and Distribution Format: % Analysis 2008
    • Table 9 Forecast Sales of OTC Healthcare by Sector: Value 2008-2013
    • Table 10 Forecast Sales of OTC Healthcare by Sector: % Value Growth 2008-2013
  • Appendix
    • OTC Registration and Classification
    • De-listing Or De-reimbursement
    • Advertising
    • Packaging and Labelling
    • Distribution
    • Vitamins & Dietary Supplements Registration and Classification
    • Self-medication and Preventative Medicine
    • Generics
    • Switches
  • Summary 1 OTC Healthcare Switches 2006-2008
    • Definitions
  • Summary 2 Research Sources
    • Axellus As
    • Strategic Direction
    • Key Facts
  • Summary 3 Axellus AS : Key Facts
  • Summary 4 Axellus AS: Operational Indicators
    • Company Background
    • Production
  • Summary 5 Axellus AS: Production Statistics 2007
    • Competitive Positioning
  • Summary 6 Axellus AS: Competitive Position 2008
    • Brynild Gruppen As
    • Strategic Direction
    • Key Facts
  • Summary 7 Brynild Gruppen AS: Key Facts
  • Summary 8 Brynild Gruppen AS: Operational Indicators
    • Company Background
    • Production
    • Competitive Positioning
  • Summary 9 Brynild Gruppen AS : Competitive Position 2008
    • Midelfart Sonesson As
    • Strategic Direction
    • Key Facts
  • Summary 10 Midelfart Sonesson AS: Key Facts
  • Summary 11 Midelfart Sonesson AS: Operational Indicators
    • Company Background
    • Competitive Positioning
  • Summary 12 Midelfart Sonesson AS: Competitive Position 2008
    • Nycomed Pharma As
    • Strategic Direction
    • Key Facts
  • Summary 13 Nycomed Pharma AS: Key Facts
  • Summary 14 Nycomed Pharma AS: Operational Indicators
    • Company Background
    • Production
  • Summary 15 Nycomed Pharma AS: Production Statistics 2007
    • Competitive Positioning
  • Summary 16 Nycomed Pharma AS: Competitive Position 2008
    • Weifa As
    • Strategic Direction
    • Key Facts
  • Summary 17 Weifa AS: Key Facts
  • Summary 18 Weifa AS: Operational Indicators
    • Company Background
    • Production
  • Summary 19 Weifa AS: Production Statistics 2007
    • Competitive Positioning
  • Summary 20 Weifa AS: Competitive Position 2008
    • Headlines
    • Trends
    • Switches
    • Competitive Landscape
    • Prospects
    • Sector Data
    • Table 11 Sales of Analgesics by Subsector: Value 2003-2008
    • Table 12 Sales of Analgesics by Subsector: % Value Growth 2003-2008
    • Table 13 Herbal vs Standard Topical Analgesics 2003-2008
    • Table 14 Topical Analgesics by Format: % Value Breakdown 2004-2008
    • Table 15 Analgesics Company Shares by Value 2004-2008
    • Table 16 Analgesics Brand Shares by Value 2005-2008
    • Table 17 Forecast Sales of Analgesics by Subsector: Value 2008-2013
    • Table 18 Forecast Sales of Analgesics by Subsector: % Value Growth 2008-2013

Industry Events

Orphan & Ultra Orphan Drugs

13 Jan 10 to 14 Jan 10
Brussels, Belgium
view summary >>

2nd International Conference on Drug Discovery and Therapy

01 Feb 10 to 04 Feb 10
Dubai, United Arab Emirates
view summary >>